{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:41:05Z","timestamp":1793410865680,"version":"4.5.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173607"],"award-info":[{"award-number":["82173607"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515011684"],"award-info":[{"award-number":["2021A1515011684"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["202102080597"],"award-info":[{"award-number":["202102080597"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The association between blood lipids and cognitive function in schizophrenia is still controversial. Thus, the present study aimed to verify the association between various lipid parameters and cognitive impairment in schizophrenic patients and potential lipid pathways.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 447 adult inpatients with schizophrenia were divided into cognitive normal and cognitive impairment groups based on the Mini-Mental State Examination with a cut-off of 26. The blood lipid parameters were defined as abnormal levels based on the guideline. The liquid chromatography-mass spectrometry method was used to preliminarily explore the potential lipid metabolism pathway associated with cognitive impairment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 368 (82.3%) patients who had cognitive impairment. Herein, apolipoprotein B was positively associated with cognitive function in overall patients and age (\u226545 and &amp;lt;45 years) and sex subgroups. After excluding patients with hypertension and diabetes, ApoB was still significantly associated with cognitive function in all the patients. The associations between other lipid parameters, including non-high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglyceride, and cognitive impairment were heterogeneous in age and sex subgroups. In contrast, total cholesterol and apolipoprotein A1 were not significantly associated with cognitive impairment. Metabolomics analysis showed that metabolic pathway mainly involved sphingolipid metabolism. Meanwhile, sphinganine and 3-dehydrosphinganine were positively correlated with lipid parameters and decreased in patients with cognitive impairment as compared to those with normal cognition.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The present study suggests a positive association between lipids and cognitive function in schizophrenic patients and needs to be further verified by a prospective study.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2022.1013698","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T06:37:46Z","timestamp":1669271866000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":39,"title":["Association between lipid metabolism and cognitive function in patients with schizophrenia"],"prefix":"10.3389","volume":"13","author":[{"given":"Huamin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanyuan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianbo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1056\/NEJMra1808803","article-title":"Schizophrenia.","volume":"381","author":"Marder","year":"2019","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/schbul\/sby058","article-title":"Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016.","volume":"44","author":"Charlson","year":"2018","journal-title":"Schizophr Bull."},{"key":"B3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia.","volume":"388","author":"Owen","year":"2016","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jpsychires.2019.08.011","article-title":"Randomized controlled trial of adjunctive valproate for cognitive remediation in early course schizophrenia.","volume":"118","author":"Ibrahim","year":"2019","journal-title":"J Psychiatr Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.2147\/CIA.S162701","article-title":"Relation between cognitive impairment and treatment adherence in elderly hypertensive patients.","volume":"13","author":"Chudiak","year":"2018","journal-title":"Clin Interv Aging."},{"key":"B6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.14283\/jpad.2015.39","article-title":"Higher cognitive performance is prospectively associated with healthy dietary choices: the maine syracuse longitudinal study.","volume":"2","author":"Crichton","year":"2015","journal-title":"J Prev Alzheimers Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11065-018-9388-2","article-title":"Cognitive deficits in psychotic disorders: a lifespan perspective.","volume":"28","author":"Sheffield","year":"2018","journal-title":"Neuropsychol Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1001\/jamapsychiatry.2014.1105","article-title":"Motivational deficits and cognitive test performance in schizophrenia.","volume":"71","author":"Fervaha","year":"2014","journal-title":"JAMA Psychiatry."},{"key":"B9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s40263-022-00935-z","article-title":"Progress and pitfalls in developing agents to treat neurocognitive deficits associated with schizophrenia.","volume":"36","author":"Veselinovi\u0107","year":"2022","journal-title":"CNS Drugs."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796019000532","article-title":"Cognitive remediation in schizophrenia: the earlier the better.","volume":"29","author":"Bellani","year":"2019","journal-title":"Epidemiol Psychiatr Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.31887\/DCNS.2019.21.3\/amccleery","article-title":"Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations.","volume":"21","author":"McCleery","year":"2019","journal-title":"Dialogues Clin Neurosci."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2021.102583","article-title":"Dyslipidemia prevalence and trends among adult mental disorder inpatients in Beijing, 2005-2018: a longitudinal observational study.","volume":"57","author":"Yang","year":"2021","journal-title":"Asian J Psychiatr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jpsychires.2018.02.012","article-title":"Obesity, dyslipidemia and brain age in first-episode psychosis.","volume":"99","author":"Kolenic","year":"2018","journal-title":"J Psychiatr Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.neurobiolaging.2007.10.019","article-title":"Higher total cholesterol, cognitive decline, and dementia.","volume":"30","author":"Panza","year":"2009","journal-title":"Neurobiol Aging."},{"key":"B15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00406-019-01017-w","article-title":"Improvement in verbal learning over the first year of antipsychotic treatment is associated with serum HDL levels in a cohort of first episode psychosis patients.","volume":"270","author":"Gjerde","year":"2020","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"16353","DOI":"10.18632\/aging.203161","article-title":"Association between cognitive impairment and apolipoprotein A1 or apolipoprotein B levels is regulated by apolipoprotein E variant rs429358 in patients with chronic schizophrenia.","volume":"13","author":"Rao","year":"2021","journal-title":"Aging."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.clnu.2019.10.017","article-title":"Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer\u2019s disease patients with APOE4(-\/-): a double-blind, randomized, placebo-controlled crossover trial.","volume":"39","author":"Xu","year":"2020","journal-title":"Clin Nutr."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.691423","article-title":"Long-term increase in cholesterol is associated with better cognitive function: evidence from a longitudinal study.","volume":"13","author":"Liu","year":"2021","journal-title":"Front Aging Neurosci."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8957541","article-title":"Serum metabolomics of early postoperative cognitive dysfunction in elderly patients using liquid chromatography and Q-TOF mass spectrometry.","volume":"2020","author":"Qian","year":"2020","journal-title":"Oxid Med Cell Longev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ijnp\/pyaa066","article-title":"Treatment discontinuation impact on long-term (10-year) weight gain and lipid metabolism in first-episode psychosis: results from the PAFIP-10 cohort.","volume":"24","author":"V\u00e1zquez-Bourgon","year":"2021","journal-title":"Int J Neuropsychopharmacol."},{"key":"B21","first-page":"1","article-title":"2016 Chinese guidelines for the management of dyslipidemia in adults.","volume":"15","year":"2018","journal-title":"J Geriatr Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.schres.2006.11.019","article-title":"Screening for cognitive functioning in psychiatric outpatients with schizophrenia, alcohol dependence, and dual diagnosis.","volume":"91","author":"Manning","year":"2007","journal-title":"Schizophr Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1017\/S1041610215000459","article-title":"Correlation between age and MMSE in schizophrenia.","volume":"27","author":"Maltais","year":"2015","journal-title":"Int Psychogeriatr."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/nu13113974","article-title":"Evaluation of available cognitive tools used to measure mild cognitive decline: a scoping review.","volume":"13","author":"Chun","year":"2021","journal-title":"Nutrients."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12008","article-title":"Plasma lipids as biomarkers for Alzheimer\u2019s disease: a systematic review.","volume":"12","author":"Agarwal","year":"2020","journal-title":"Cureus."},{"key":"B26","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/ana.20289","article-title":"Serum lipids and hippocampal volume: the link to Alzheimer\u2019s disease.","volume":"56","author":"Wolf","year":"2004","journal-title":"Ann Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1111\/ene.14947","article-title":"The association between cardiovascular risk burden and cognitive function amongst the old: a 9-year longitudinal cohort study.","volume":"28","author":"Wu","year":"2021","journal-title":"Eur J Neurol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.705043","article-title":"Subclinical carotid artery atherosclerosis and cognitive function: a mini-review.","volume":"12","author":"Ihle-Hansen","year":"2021","journal-title":"Front Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.schres.2011.04.005","article-title":"Cholesterol and cognition in schizophrenia: a double-blind study of patients randomized to clozapine, olanzapine and haloperidol.","volume":"130","author":"Krakowski","year":"2011","journal-title":"Schizophr Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/JGP.0b013e3181812790","article-title":"Better memory functioning associated with higher total and low-density lipoprotein cholesterol levels in very elderly subjects without the apolipoprotein e4 allele.","volume":"16","author":"West","year":"2008","journal-title":"Am J Geriatr Psychiatry."},{"key":"B31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s12603-016-0701-6","article-title":"Serum cholesterol levels within the high normal range are associated with better cognitive performance among chinese elderly.","volume":"20","author":"Lv","year":"2016","journal-title":"J Nutr Health Aging."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.656623","article-title":"Elevated HDL levels linked to poorer cognitive ability in females with Parkinson\u2019s disease.","volume":"13","author":"Bakeberg","year":"2021","journal-title":"Front Aging Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1194\/jlr.P119000473","article-title":"High density lipoprotein and its apolipoprotein-defined subspecies and risk of dementia.","volume":"61","author":"Koch","year":"2020","journal-title":"J Lipid Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/j.1582-4934.2012.01543.x","article-title":"Potential biomarkers in psychiatry: focus on the cholesterol system.","volume":"16","author":"Woods","year":"2012","journal-title":"J Cell Mol Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/acn3.51153","article-title":"Association of serum apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer\u2019s pathology.","volume":"7","author":"Hu","year":"2020","journal-title":"Ann Clin Transl Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis.","volume":"21","author":"Luo","year":"2020","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-017-0437-2","article-title":"Serum lipid profile as a marker of liver impairment in hepatitis B cirrhosis patients.","volume":"16","author":"Arain","year":"2017","journal-title":"Lipids Health Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1111\/liv.14161","article-title":"Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: the framingham study.","volume":"39","author":"Weinstein","year":"2019","journal-title":"Liver Int."},{"key":"B39","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S2468-1253(18)30244-9","article-title":"Liver disease in the young adult: the challenges and rewards.","volume":"4","author":"Thompson","year":"2019","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9638797","article-title":"Cognitive changes and brain volume reduction in patients with nonalcoholic fatty liver disease.","volume":"2018","author":"Filipovi\u0107","year":"2018","journal-title":"Can J Gastroenterol Hepatol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.707958","article-title":"The effect and mechanism of cholesterol and vitamin B(12) on multi-domain cognitive function: a prospective study on chinese middle-aged and older adults.","volume":"13","author":"Wang","year":"2021","journal-title":"Front Aging Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-1-4020-8831-5_9","article-title":"Altered lipid metabolism in brain injury and disorders.","volume":"49","author":"Adibhatla","year":"2008","journal-title":"Subcell Biochem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/eurjpc\/zwab230","article-title":"High-density lipoprotein cholesterol and cardiovascular mortality: a prospective cohort study among 15.8 million adults.","volume":"29","author":"Yi","year":"2022","journal-title":"Eur J Prev Cardiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.yhbeh.2014.08.011","article-title":"Estradiol and cognitive function: past, present and future.","volume":"66","author":"Luine","year":"2014","journal-title":"Horm Behav."},{"key":"B45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40618-015-0332-5","article-title":"Neuroprotective effects of estrogens: the role of cholesterol.","volume":"39","author":"Peri","year":"2016","journal-title":"J Endocrinol Invest."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.psyneuen.2012.01.007","article-title":"Estrogens and memory in physiological and neuropathological conditions.","volume":"37","author":"Pompili","year":"2012","journal-title":"Psychoneuroendocrinology."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00622","article-title":"Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia.","volume":"9","author":"MacKenzie","year":"2018","journal-title":"Front Psychiatry."},{"key":"B48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1586\/ern.09.143","article-title":"Effect of second-generation antipsychotics on cognition: current issues and future challenges.","volume":"10","author":"Hill","year":"2010","journal-title":"Expert Rev Neurother."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5243453","article-title":"Integrated metabolomic and lipidomic analysis reveals the neuroprotective mechanisms of bushen tiansui formula in an a\u03b21-42-induced rat model of Alzheimer\u2019s disease.","volume":"2020","author":"Yi","year":"2020","journal-title":"Oxid Med Cell Longev."},{"key":"B50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.toxlet.2020.11.020","article-title":"Repeated low-dose exposures to sarin disrupted the homeostasis of phospholipid and sphingolipid metabolism in guinea pig hippocampus.","volume":"338","author":"Shi","year":"2021","journal-title":"Toxicol Lett."},{"key":"B51","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/jnr.24750","article-title":"Targeted metabolomics study of early pathological features in hippocampus of triple transgenic Alzheimer\u2019s disease male mice.","volume":"99","author":"Zhao","year":"2021","journal-title":"J Neurosci Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrm.2017.16","article-title":"The mystery of membrane organization: composition, regulation and roles of lipid rafts.","volume":"18","author":"Sezgin","year":"2017","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1194\/jlr.R075630","article-title":"Cellular cholesterol homeostasis and Alzheimer\u2019s disease.","volume":"58","author":"Chang","year":"2017","journal-title":"J Lipid Res."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.1013698\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T06:37:53Z","timestamp":1669271873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.1013698\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":53,"alternative-id":["10.3389\/fpsyt.2022.1013698"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.1013698","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,24]]},"article-number":"1013698"}}